Navigant Consulting 10-Q 28 Oct 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Oct. 26, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Entity Registrant Name	NAVIGANT CONSULTING INC
Entity Central Index Key	1,019,737
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		47,580,538
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,015
Trading Symbol	nci

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 4,017	$ 2,648
Accounts receivable, net	221,159	187,652
Prepaid expenses and other current assets	30,536	27,142
Deferred income tax assets	15,283	13,455
Total current assets	270,995	230,897
Non-current assets:
Property and equipment, net	75,575	60,617
Intangible assets, net	26,830	26,502
Goodwill	579,876	568,091
Other assets	23,746	17,386
Total assets	977,022	903,493
Current liabilities:
Accounts payable	9,104	11,735
Accrued liabilities	12,959	11,311
Accrued compensation-related costs	79,006	83,061
Income tax payable	4,512	1,763
Other current liabilities	37,641	52,526
Total current liabilities	143,222	160,396
Non-current liabilities:
Deferred income tax liabilities	84,385	76,329
Other non-current liabilities	20,645	14,387
Bank debt non-current	146,814	109,790
Total non-current liabilities	251,844	200,506
Total liabilities	395,066	360,902
Stockholders' equity:
Common stock	64	64
Additional paid-in capital	625,484	611,882
Treasury stock	(293,810)	(275,608)
Retained earnings	265,483	218,337
Accumulated other comprehensive loss	(15,265)	(12,084)
Total stockholders' equity	581,956	542,591
Total liabilities and stockholders' equity	$ 977,022	$ 903,493

Consolidated Statements Of Comp

Consolidated Statements Of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements Of Comprehensive Income (Loss) [Abstract]
Revenues before reimbursements	$ 209,634	$ 205,534	$ 621,813	$ 567,094
Reimbursements	20,624	24,605	65,055	68,890
Total revenues	230,258	230,139	686,868	635,984
Cost of services before reimbursable expenses	141,731	135,859	425,699	382,779
Reimbursable expenses	20,624	24,605	65,055	68,890
Total costs of services	162,355	160,464	490,754	451,669
General and administrative expenses	36,629	34,067	111,362	101,406
Depreciation expense	5,954	5,116	17,033	14,378
Amortization expense	2,084	1,673	6,650	4,668
Contingent acquisition liability adjustments, net		(834)	(12,625)	(4,438)
Office consolidation, net			2,740
Loss on disposition of assets	283		283
Goodwill impairment				122,045
Other impairment			98	204
Operating income (loss)	22,953	29,653	70,573	(53,948)
Interest expense	1,018	1,942	3,988	4,177
Interest income	(77)	(56)	(178)	(216)
Other (income) expense, net	(328)	(57)	(480)	211
Income (loss) from continuing operations before income tax (benefit) expense	22,340	27,824	67,243	(58,120)
Income tax (benefit) expense	8,164	11,563	20,097	(8,892)
Net income (loss) from continuing operations	14,176	16,261	47,146	(49,228)
Income from discontinued operations, net of tax				509
Net income (loss)	$ 14,176	$ 16,261	$ 47,146	$ (48,719)
Basic per share data
Net income (loss) from continuing operations	$ 0.30	$ 0.33	$ 0.98	$ (1.01)
Income from discontinued operations, net of tax				0.01
Net income (loss)	$ 0.30	$ 0.33	$ 0.98	$ (1)
Shares used in computing basic per share data	47,835	48,736	48,036	48,856
Diluted per share data
Net income (loss) from continuing operations	$ 0.29	$ 0.33	$ 0.96	$ (1.01)
Income from discontinued operations, net of tax				0.01
Net income (loss)	$ 0.29	$ 0.33	$ 0.96	$ (1)
Shares used in computing diluted per share data	49,155	49,827	49,297	48,856
Net income (loss)	$ 14,176	$ 16,261	$ 47,146	$ (48,719)
Other comprehensive loss, net of tax
Unrealized net loss, foreign currency translation	(2,723)	(950)	(2,967)	(258)
Unrealized net gain (loss) on interest rate derivatives	(186)	5	(450)	(29)
Reclassification adjustment on interest rate derivatives included in interest expense and income tax expense	81	72	236	149
Other comprehensive loss, net of tax	(2,828)	(873)	(3,181)	(138)
Total comprehensive income (loss), net of tax	$ 11,348	$ 15,388	$ 43,965	$ (48,857)

Consolidated Statements Of Stoc

Consolidated Statements Of Stockholders' Equity - 9 months ended Sep. 30, 2015 - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2014	$ 64	$ (275,608)	$ 611,882	$ (12,084)	$ 218,337	$ 542,591
Balance, shares at Dec. 31, 2014	63,708	(15,491)
Comprehensive income (loss)				(3,181)	47,146	43,965
Issuances of common stock			5,488			5,488
Issuances of common stock, shares	455
Tax benefits on stock options exercised and restricted stock units vested			249			249
Vesting of restricted stock and restricted stock units, net of forfeitures and tax withholdings		$ 5	(1,633)			(1,628)
Vesting of restricted stock and restricted stock units, net of forfeitures and tax withholdings, shares	252
Share-based compensation expense			8,206			8,206
Additional paid-in capital recorded through compensation expense			1,292			1,292
Repurchases of common stock		$ (18,207)				(18,207)
Repurchases of common stock, shares		(1,247)
Balance at Sep. 30, 2015	$ 64	$ (293,810)	$ 625,484	$ (15,265)	$ 265,483	$ 581,956
Balance, shares at Sep. 30, 2015	64,415	(16,738)

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income (loss)	$ 47,146	$ (48,719)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	17,033	14,378
Accelerated depreciation - office consolidation	139
Amortization expense	6,650	4,668
Amortization expense - client-facing software	676	825
Share-based compensation expense	8,206	7,166
Accretion of interest expense	1,164	1,565
Deferred income taxes	6,710	(21,202)
Allowance for doubtful accounts receivable	1,692	4,309
Contingent acquisition liability adjustments, net	(12,625)	(4,438)
Loss on disposition of assets	283
Gain on disposition of discontinued operations		(509)
Goodwill impairment		122,045
Other impairment	98	204
Changes in assets and liabilities (net of acquisitions and dispositions):
Accounts receivable	(35,687)	(38,522)
Prepaid expenses and other assets	(7,717)	(778)
Accounts payable	(2,685)	(3,021)
Accrued liabilities	2,171	(1,125)
Accrued compensation-related costs	(3,748)	(10,909)
Income taxes payable	979	6,113
Other liabilities	3,618	(5,157)
Net cash provided by operating activities	34,103	26,893
Cash flows from investing activities:
Purchases of property and equipment	(31,160)	(15,065)
Acquisitions of businesses, net of cash acquired	(21,379)	(89,180)
Proceeds from disposition, net of selling costs		824
Payments of acquisition liabilities	(2,196)	(1,110)
Capitalized client-facing software	(611)	(864)
Net cash used in investing activities	(55,346)	(105,395)
Cash flows from financing activities:
Issuances of common stock	5,488	2,431
Repurchases of common stock	(18,207)	(20,797)
Payments of contingent acquisition liabilities	(592)	(107)
Repayments to banks	(230,633)	(231,201)
Borrowings from banks	268,014	332,947
Other, net	(1,299)	(2,474)
Net cash provided by financing activities	22,771	80,799
Effect of exchange rate changes on cash and cash equivalents	(159)	(13)
Net increase in cash and cash equivalents	1,369	2,284
Cash and cash equivalents at beginning of the period	2,648	1,968
Cash and cash equivalents at end of the period	4,017	4,252
Supplemental Consolidated Cash Flow Information
Interest paid	2,368	1,991
Income taxes paid, net of refunds	$ 11,630	$ 4,110

Description Of Business And Bas

Description Of Business And Basis Of Presentation	9 Months Ended
	Sep. 30, 2015
Description Of Business And Basis Of Presentation [Abstract]
Description Of Business And Basis Of Presentation	1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Navigant Consulting, Inc. (“we,” “us,” or “our”) is an independent specialized, global professional services firm that combines deep industry knowledge with technical expertise to enable companies to defend, protect and create value. We focus on industries and clients facing transformational change and significant regulatory and legal issues. We serve clients primarily in the healthcare, energy and financial services sectors which represent highly complex market and regulatory environments. Our professional service offerings include strategic, financial, operational, technology, risk management, compliance, investigative solutions, dispute resolution services and business process management services. We provide our services to companies, legal counsel and governmental agencies. Our business is organized in four reporting segments — Disputes, Investigations & Economics; Financial, Risk & Compliance; Healthcare; and Energy. The accompanying unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim reporting and do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America (GAAP). The information contained herein includes all adjustments, consisting of normal and recurring adjustments except where indicated, which are, in the opinion of management, necessary for a fair presentation of the results of operations for the interim periods presented. The results of operations for the nine months ended September 30, 2015 are not necessarily indicative of the results to be expected for the enti re year ending December 31, 2015 . These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes as of and for the year ended December 31, 2014 included in our Annual Report on Form 10-K filed with the SEC on February 1 3, 2015 (201 4 10-K). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and the related notes. Actual results could differ from those estimates and may affect future results of operations and cash flows. We have evaluated events and transactions occurring after the balance sheet date and prior to the date of the filing of this report.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2015
Acquisitions [Abstract]
Acquisitions	2 . ACQUISITIONS 2015 Acquisitions On February 23, 2015 , we acquired RevenueMed, Inc. to expand our healthcare business. RevenueMed specializes in providing coding, revenue cycle management, and business process management services to healthcare providers. This acquisition included approximately 1,500 professionals primarily located in India and was integrated into the Technology, Data & Process business within our Healthcare segment. We paid $22.1 million, including selling costs, in cash at closing. The purchase agreement provided for a deferred contingent acquisition payment to the selling stockholders of RevenueMed in an amount up to $4.0 million based on the business achieving certain performance targets over the period beginning January 1, 2015 and ending June 30, 2015 . We estimated the fair value of the deferred contingent consideration on the closing date to be $3.8 million which was recorded in other current liabilities at net present value using a risk-adjusted discount rate. Based on the acquired business’ operating results during the performance period, the maximum earned amount was achieved, and on October 1, 2015 , a $4.0 million cash payment was made to settle the contingent acquisition liability. As part of our preliminary purchase price allocation, we recorded $7.0 million in identifiable intangible assets, $14.9 million in goodwill, $1.4 million of internally developed software and other n et assets of $2.6 million. Other net assets included a liability for uncertain tax positions of $1.3 million, and based on the indemnification terms of the purchase agreement, which entitles us to indemnification if tax is due, an offsetting receivable from RevenueMed was recorded in prepaid expenses and other current assets. We are still in the process of finalizing our purchase price allocation and the assumptions used to determine the fair value of the intangible assets. In addition, as we complete our review, we may come across additional closing date adjustments not currently recognized in the unaudited consolidated financial statements. These adjustments may revise our preliminary purchase price allocation. Post-acquisition adjustments relating to facts and circumstances at the closing date, if any, will be recorded to goodwill when identified for a period not exceeding 12 months. 2014 Acquisitions On May 14, 2014 , we acquired Cymetrix Corporation to expand our healthcare business. Cymetrix specializes in providing business process management services to hospital and healthcare networks. This acquisition included approximately 600 professionals and was integrated into the Technology, Data & Process business within our Healthcare segment. We paid $76.9 million, including selling costs, in cash at closing. The terms of the original agreement included deferred contingent consideration to be paid to the selling stockholders of Cymetrix of up to $25.0 million based on the business achieving certain performance targets over the period beginning November 1, 2014 and ending October 31, 2015 . The deferred contingent consideration fair value was estimated on the closing date to be $ 20.3 million which was recorded in other non-current liabilities at net present value using a risk-adjusted discount rate. During the nine months ended September 30, 2015, we recorded $15.4 million of other operating benefit reflecting a fair value adjustment (see Note 12 — Fair Value). On May 15, 2015 , we signed an amendment to the original agreement which effectively changed the deferred contingent consideration to a fixed cash payment of $10.0 million to be paid on or before December 31, 2015. During the nine months ended September 30, 2015, we removed the contingency and recorded $2.1 million of other operating costs reflecting a fair value adjustment. This resulted in a definitive deferred acquisition liability of $10.0 million . In accordance with our final purchase price allocation we recorded $1.4 million in cash, $11.3 million in accounts receivable, net, $1.6 million in other current assets, $11.8 million in property and equipment, net, $71.3 million in goodwill, $18.0 million in identifiable intangible assets, and $36.9 million in total liabilities. Also, during 2014, we acquired three small businesses, Leerink Swann Consulting (Leerink) in April 2014, HLP Consulting PTE. LTD (HLP) in June 2014 and Assay Healthcare Solutions, LLC (Assay) in August 2014 for an aggregate purchase price of $11.8 million, of which $9.3 million was paid in cash at closing. Leerink and Assay were integrated into our Healthcare segment, and HLP was integrated into our Disputes, Investigations & Economics segment. See Note 12 – Fair Value for additional information regarding deferred contingent consideration fair value adjustments. Pro Forma Information The following supplemental unaudited pro forma financial information was prepared as if the 2015 and 2014 acquisitions noted above had occurred as of January 1, 2014. The following table was prepared for comparative purposes only and does not purport to be indicative of what would have occurred had the acquisitions been made at that time or of results which may occur in the future (in thousands, except per share data). For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Total revenues $ $ $ $ Net income (loss) from continuing operations $ $ $ $ Basic net income (loss) from continuing operations per basic share $ $ $ $ Shares used in computing net income (loss) per basic share Diluted net income (loss) from continuing operations per diluted share $ $ $ $ Shares used in computing net income (loss) per diluted share

Dispositions

Dispositions	9 Months Ended
	Sep. 30, 2015
Dispositions [Abstract]
Dispositions	3. DISPOSITIONS On October 1, 2014 , we sold a portion of our Technology, Data & Process business within our Healthcare segment. We received $1.5 million in cash, net of selling costs, for the sale. As part of the transaction, we recorded a $0.5 million gain in other operating costs (benefit), which reflected a reduction of $0.8 million in goodwill, $0.1 million in intangible assets, and $0.2 million in other assets. The Technology, Data & Process business within our Healthcare segment remains a continuing operation and, as such, this transaction did not qualify as discontinued operations.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2015
Segment Information [Abstract]
Segment Information	4 . SEGMENT INFORMATION Our business is assessed and resources are allocated based on the following four reportable segments: • The Disputes, Investigations & Economics segment provides accounting, financial and economic analysis, as well as discovery support, data management and analytics, on a wide range of legal and business issues including disputes, investigations and regulatory matters. The clients of this segment are principally companies, along with their in-house counsel and law firms, as well as accounting firms, corporate boards and government agencies. • The Financ ial, Risk & Compliance segment provides strategic, operational, valuation, risk management, investigative and compliance consulting to clients in the highly regulated financial services industry, including major financial and insurance institutions. This segment also pro vides anti-corruption solutions and anti-money laundering, valuation and restructuring consulting , litigation support and tax compliance services to clients in a broad variety of industries. • The Healthcare segment provides strategic, operational, performance improvement and business process management services which includes solutions to clients across the healthcare landscape including health systems, physician practice groups, health insurance providers, government and life sciences companies. We assist clients on issues such as the shift to an outcomes and value-based reimbursements model, ongoing industry consolidation and reorganization, the required implementation of a new medical coding system and the implications of maximizing the effects of revenue cycle management. • The Energy segment provides management advisory services to utility, government and commercial clients. We focus on creating value for our clients by assisting in their implementation of new business models and creating sustainable excellence on issues ranging from asset investment management, integrated resource planning, renewables, distributed generation, energy efficiency and outage management and restoration . The following information includes segment revenues before reimbursements, segment total revenues and segment operating profit. Certain unallocated expense amounts related to specific reporting segments have been excluded from segment operating profit to be consistent with the information used by management to evaluate segment performance. Segment operating profit represents total revenues less cost s of services excluding long-term compensation expense attributable to c lient-service employees . Long-term compensation expense attributable to client-service employees includes share-based compensation expense and compensation expense attributed to certain retention incentives (see Note 7 — Share-based Compensation Expense and Note 8 — Supplemental Consolidated Balance Sheet Information). The information presented does not necessarily reflect the results of segment operations that would have occurred had the segments been stand-alone businesses. Information on the segment operations has been summar ized as follows (in thousands): For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Revenues before reimbursements: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total revenues before reimbursements $ $ $ $ Total revenues: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total revenues $ $ $ $ Segment operating profit: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total segment operating profit Segment reconciliation to income (loss) from continuing operations before income tax expense (benefit): Reconciling items: General and administrative expenses Depreciation expense Amortization expense Other operating costs (benefit), net Long-term compensation expense attributable to client-service employees (including share-based compensation expense) Operating income (loss) Interest and other expense, net Income (loss) from continuing operations before income tax expense (benefit) $ $ $ $ Total assets allocated by segment include accounts receivable (net), certain retention-related prepaid assets, intangible assets and goodwill. The remaining assets are unallocated. Allocated assets by segment were as follows (in thousands): September 30, December 31, 2015 2014 Disputes, Investigations & Economics $ $ Financial, Risk & Compliance Healthcare Energy Unallocated assets Total assets $ $

Goodwill And Intangible Assets,

Goodwill And Intangible Assets, Net	9 Months Ended
	Sep. 30, 2015
Goodwill And Intangible Assets, Net [Abstract]
Goodwill And Intangible Assets, Net	5 . GOOD WILL AND INTANGIBLE ASSETS, NET Goodwill consisted of (in thousands): September 30, December 31, 2015 2014 Goodwill $ $ Less - accumulated amortization Less - accumulated goodwill impairment Goodwill, net $ $ Changes made to our goodwill balances during the nine months ended September 30, 2015 and 2014 were as follows (in thousands): Disputes, Financial, Investigations Risk & Total & Economics Compliance Healthcare Energy Company Goodwill, net as of January 1, 2014 $ $ $ $ $ Acquisitions - - Impairment - - - Adjustments - Foreign currency - Goodwill, net as of September 30, 2014 $ $ $ $ $ Goodwill, net as of January 1, 2015 Acquisitions - - - Adjustments - Foreign currency Goodwill, net as of September 30, 2015 $ $ $ $ $ We performed our annual goodwill impairment test as of May 31, 2015 (see Note 2 – Summary of Significant Accounting Policies in our 2014 10-K). The key assumptions included: internal projections completed during our second quarter 2015 forecasting process; profit margin improvement generally consistent with our longer-term historical performance; assumptions regarding contingent revenue; revenue growth rates consistent with our longer-term historical performance also considering our near term investment plans and growth objectives; discount rates that were determined based on comparable discount rates for our peer group; company specific risk considerations; and cost of capital based on our historical experience. Each reporting unit’s estimated fair value depends on various factors including its expected ability to achieve profitable growth. Based on our assumptions, at that time, the estimated fair value exceeded the net asset carrying value for each of our reporting units as of May 31, 201 5 . Accordingly, there was no indication of impairment of our goodwill for any of our reporting units. As of May 31, 2015, the estimated fair value of our Disputes, Investigations & Economics, Healthcare, Energy and Financial, Risk & Compliance reporting units exceeded their net asset carrying values by 16% , 25% , 32% and 61% , respectively. We have reviewed our most recent financial projections and considered the impact of changes to our business and market conditions on our goodwill valuation and determined that no events or conditions have occurred or are expected to occur that would trigger a need to perform an interim goodwill impairment test. We will continue to monitor the factors and key assumptions used in determining the fair value of each of our reporting units. There can be no assurance that goodwill or intangible assets will not be impaired in the future. We will perform our next annual goodwill impair ment test as of May 31, 2016 . In our 2014 annual impairment test, the estimated fair value of our Disputes, Investigations & Economics reporting unit was less than its net asset carrying value by approximately 1% as of May 31, 2014. As such, we performed the second step of the goodwill impairment test on this reporting unit, and based on the result in May 2014 , a pre-tax goodwill impairment of $122.0 million was recorded as a separate line item within other operating costs (benefit) during the quarter ended June 30, 2014 . The impairment was non-cash in nature and did not affect our liquidity, cash flows, borrowing capability or operations , nor did it impact the debt covenants under our credit agreement. For further information regarding the impairment, see Note 6 – Goodwill and Intangible Assets, Net in our 2014 10-K. As we review our portfolio of services in the future, we may exit certain markets or reposition certain service offerings within our business. Consistent with past evaluations, further evaluations may result in redefining our operating segments and may impact a significant portion of one or more of our reporting units. If such actions occur, they may be considered triggering events that would result in our performing an interim impairment test of our goodwill and an impairment test of our intangible assets. Intangible assets consisted of (in thousands): September 30, December 31, 2015 2014 Intangible assets: Customer lists and relationships $ $ Non-compete agreements Other Intangible assets, at cost Less: accumulated amortization Intangible assets, net $ $ Our intangible assets have estimated remaining useful lives ranging up to ten years which approximate the estimated periods of consumption. We will amortize the remaining net book values of intangible assets over their remaining useful lives. At September 30, 2015 , our intangible assets consisted of the following (in thousands, except year data): Weighted Average Category Remaining Years Amount Customer lists and relationships, net 6.8 $ Non-compete agreements, net 3.5 Other intangible assets, net 2.7 Total intangible assets, net 6.2 $ Total amortization expense was $ 6.7 million and $ 4.7 million for the nine months ended September 30, 2015 and 201 4 , respectively. Below is the estimated annual aggregate amortization expense to be recorded in future periods related to intangible assets at September 30, 2015 (in thousands): Year Ending December 31, Amount 2015 ( October -December) $ 2016 2017 2018 2019 Thereafter Total $

Net Income Per Share (EPS)

Net Income Per Share (EPS)	9 Months Ended
	Sep. 30, 2015
Net Income Per Share (EPS) [Abstract]
Net Income Per Share (EPS)	6. NET INCOME PER SHARE (EPS) The components of basic and diluted shares (in thousands and based on the weighted average days outstanding for the periods) are as follows: For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Basic shares Employee stock options - Restricted stock and restricted stock units - Contingently issuable shares - Diluted shares Antidilutive shares (1) (1) Stock options with exercise prices greater than the average market price of our common stock during the respective time periods were excluded from the computation of diluted shares because the impact of including the shares subject to these stock options in the diluted share calculation would have been antidilutive. Due to a net loss applicable to common stockholders for the nine months ended September 30, 2014, we excluded 1,256 in potentially dilutive securities from the computation for the same period as their effect would be antidilutive.

Share-Based Compensation Expens

Share-Based Compensation Expense	9 Months Ended
	Sep. 30, 2015
Share-Based Compensation Expense [Abstract]
Share-Based Compensation Expense	7 . SHARE-BASED COMPENSATION EXPENSE Share-based compensation expense is recorded for restricted stock, restricted stock units, stock options and the discount given on employee stock purchase plan transactions. The following table shows the amounts attributable to each category (in thousands): For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Amortization of restricted stock and restricted stock unit awards $ $ $ $ Amortization of stock option awards Discount given on employee stock purchase transactions through our Employee Stock Purchase Plan Total share-based compensation expense $ $ $ $ Total share-based compensation expense consisted of the following (in thousands): For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Cost of services before reimbursable expenses $ $ $ $ General and administrative expenses Total share-based compensation expense $ $ $ $ Share-based compensation expense attributable to client-service employees was included in cost of services before reimbursable expenses. Share-based compensation expense attributable to corporate management and support personnel was included in general and administrative expenses. At September 30, 2015 , we had $16.2 million of total compensation costs related to unvested share-based awards that have not been recognized as share-based compensation expense. The compensation costs will be recognized as an expense over the remaining vesting periods. The weighted average remaining vesting period is approximately two years. During the nine months ended September 30, 2015 , we granted an aggregate of 1,158,311 share-based awards, consisting of restricted stock units and stock options with an aggregate fair value of $14.8 million at the time of grant. These grants include certain awards that vest based on relative achievement of pre-established performance criteria.

Supplemental Consolidated Balan

Supplemental Consolidated Balance Sheet Information	9 Months Ended
	Sep. 30, 2015
Supplemental Consolidated Balance Sheet Information [Abstract]
Supplemental Consolidated Balance Sheet Information	8 . SUPPLEMENTAL CONSOLIDATED BALANCE SHEET INFORMATION Accounts Receivable, net The components of accounts receivable were as follows (in thousands): September 30, December 31, 2015 2014 Billed amounts $ $ Engagements in process Allowance for uncollectible billed amounts Allowance for uncollectible engagements in process Accounts receivable, net $ $ Receivables attributable to engagements in process represent balances for services that have been performed and earned but have not been billed to the client. Services are generally billed on a monthly basis for the prior month’s services. Our allowance for uncollectible accounts is based on historical experience and management judgment and may change based on market conditions or specific client circumstances. Prepaid Expenses and Other Current Assets The components of prepaid expenses and other current assets were as follows (in thousands): September 30, December 31, 2015 2014 Notes receivable - current $ $ Prepaid recruiting and retention incentives - current Other prepaid expenses and other current assets Prepaid expenses and other current assets $ $ Other Assets The components of other assets were as follows (in thousands): September 30, December 31, 2015 2014 Notes receivable - non-current $ $ Capitalized client-facing software Prepaid recruiting and retention incentives - non-current Prepaid expenses and other non-current assets Other assets $ $ Notes receivable, current and non-current, represent unsecured employee loans. These loans were issued to recruit or r etain certain senior-level client-service employees . During the nine months ended September 30, 2015 , we issued unsecured employee loans aggregating $4.9 million, and during the nine months ended September 30, 2014, no such loans were issued. The principal amount and accrued interest on these loans is either paid by the employee or forgiven by us over the term of the loans so long as the employee remains continuously employed by us and complies with certain contractual requirements. The expense associated with the forgiveness of the principal amount of the loans is amortized as compensation expense over the service period, which is consistent with the term of the loans. Capitalized client-facing software is used by our clients as part of client engagements. These amounts are amortized into cost of services before reimbursable expenses over their estimated remaining useful life. During the nine months ended September 30, 2015 and 2014, we capitalized or acquired $ 0.6 million and $ 2.4 million, respectively, in capitalized client-facin g software . In addition, during the nine months ended September 30, 2015 , we transferred $ 0.5 million of developed software from capitalized client-facing software included in other assets into property and equipment, net due to a change in scope for its use. Prepaid recruiting and retention incentives, current and non-current, include sign-on and retention bonuses that are generally recoverable from an employee if the employee voluntarily terminates employment or if the employee’s employment is terminated for “cause” prior to fulfilling his or her obligations to us. These amounts are amortized as compensation expense over the period in which they are recoverable from the employee, generally in periods up to six years. During the nine months ended September 30, 2015 and 2014 , we granted $18.5 million and $11.2 million, respectively, of sign-on and retention bonuses, which have been included in current and non-current prepaid recruiting and retention incentives. Property and Equipment, net Property and equipment, net consisted of (in thousands): September 30, December 31, 2015 2014 Furniture, fixtures and equipment $ $ Software Leasehold improvements Property and equipment, at cost Less: accumulated depreciation and amortization Property and equipment, net $ $ During the nine months ended September 30, 2015 , we invested $ 31.2 million in property and equipment which included $13.8 million in our technology infrastructure and software ( of which $2.3 million was previously accrued), $14.0 million in leasehold improvements mainly relating to the build-out of our new consolidated office space located in New York, New York , and $3.4 million in furniture . During the three months ended September 30, 2015, we received a $1.1 million tenant allowance relating to the leasehold improvements. During the nine months ended September 30, 2015, we disposed of $19.9 million in fully depreciated assets. In addition, we acquired $2.3 million in property and equipment relating to our RevenueMed acquisition and transferred $ 0.5 million of developed software from capitalized client-facing software included in other assets into property and equipment, net due to a change in scope for its use . Other Current Liabilities The components of other current liabilities were as follows (in thousands): September 30, December 31, 2015 2014 Deferred acquisition liabilities $ $ Deferred revenue Deferred rent - short term Other current liabilities Total other current liabilities $ $ Other Non-Current Liabilities The components of other non-current liabilities were as follows (in thousands): September 30, December 31, 2015 2014 Deferred acquisition liabilities $ $ Deferred rent - long term Other non-current liabilities Total other non-current liabilities $ $ D eferred acquisition liabilities , current and non-current, at September 30, 2015 consisted of cash obligations related to definitive and contingent purchase price considerations recorded at net present value and fair value, respectively. During the nine months ended September 30, 2015 , we reduced the deferred contingent acquisition liabilities by $ 12.6 million relating to net fair value adjustments and added $ 3.8 million in deferred contingent acquisition liabilities relating to the RevenueMed acquisition (see Note 12 – Fair Value and Note 2 – Acquisitions ). The current and non-current portion s of deferred rent relates to tenant allowances and incentives on lease arrangements for our office facilities that expire at various dates through 2025 . At September 30, 2015 , other non-current liabilities included $1.1 million of performance-based long-term incentive compensation liabilities. As part of our long-term incentive plan, we issue restricted stock units which vest three years from the grant date to select senior-level client-service employees and leaders based on the achievement of certain performance targets during the prior year. Deferred revenue represents advance billings to our clients for services that have not yet been performed and earned.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2015
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	9. ACCUMULATED OTHER COMPREHENSIVE LOSS The following table summarizes the activity in accumulated other comprehensive loss (in thousands): For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Unrealized loss on foreign exchange: Balance at beginning of period $ $ $ $ Unrealized loss on foreign exchange Balance at end of period $ $ $ $ Unrealized gain (loss) on derivatives: Balance at beginning of period $ $ $ $ Unrealized gain (loss) on derivatives in period, net of reclassification Reclassified to interest expense Income tax expense Balance at end of period $ $ $ $ 2015 2014 Accumulated other comprehensive loss at September 30, $ $

Derivatives And Hedging Activit

Derivatives And Hedging Activity	9 Months Ended
	Sep. 30, 2015
Derivatives And Hedging Activity [Abstract]
Derivatives And Hedging Activity	10. DERIVATIVES AND HEDGING ACTIVITY During the nine months ended September 30, 2015 , the following interest rate derivatives were outstanding (summarized based on month of execution): Number of Total Notional Amount Month executed Contracts Beginning Date Maturity Date Rate (millions) December 2011 2 December 31, 2012 December 31, 2015 $10.0 May 2012 1 June 28, 2013 May 27, 2016 $5.0 July 2014 5 July 11, 2014 July 11, 2017 $30.0 March 2015 1 May 29, 2015 May 31, 2018 $10.0 June 2015 1 June 30, 2015 June 30, 2018 $5.0 We expect the interest rate derivatives to be highly effective against changes in cash flows related to changes in interest rates and have recorded the derivatives as a cash flow hedge. As a result, gains or losses related to fluctuations in the fair value of the interest rate derivatives are recorded as a component of accumulated other comprehensive loss and reclassified into interest expense as the variable interest expense on our bank debt is recorded. There was no ineffectiveness related to the interest rate derivatives during the nine months ended September 30, 2015 . For the nine months ended September 30, 2015 and 2014 , we recorded $0.4 million and $0.2 million , respectively, in interest expense associated with differentials received or paid under the interest rate derivatives. At September 30, 2015 , we had $ 0.5 million of net liability related to the interest rate derivatives.

Bank Debt

Bank Debt	9 Months Ended
	Sep. 30, 2015
Bank Debt [Abstract]
Bank Debt	1 1 . BANK DEBT Our credit agreement provides a $400.0 million revolving credit facility. At our option, subject to the terms and conditions specified in the credit agreement, we may elect to increase commitments under the credit facility up to an aggregate amount of $500.0 million. The credit facility becomes due and payable in full upon maturity in September 2018 . Borrowings and repayments under the credit facility may be made in multiple currencies including U.S. Dollars, Canadian Dollars, United Kingdom Pound Sterling and Euro. At September 30, 2015 , we had aggregate borrowings outstanding of $146.8 million, compared to $109.8 million at December 31, 2014 . Based on our financial covenants at September 30, 2015 , approximately $232 million in additional borrowings were available to us under the credit facility. At September 30, 2015 we had $7.6 million of unused letters of credit under our credit facility, which have been included as a reduction in the available borrowings above. The letters of credit are primarily related to the requirements of certain lease agreements for office space. At our option, borrowings under the credit facility bear interest at a variable rate equal to an applicable base rate or LIBOR, in each case plus an applicable margin. For LIBOR loans, the applicable margin varies depending upon our consolidated leverage ratio (the ratio of total funded debt to adjusted EBITDA, as defined in the credit agreement). At September 30, 2015 , the applicable margins on LIBOR and base rate loans were 1.00 % and 0.00% , respectively. Depending upon our performance and financial condition, our LIBOR loans will have applicable margins varying between 1.00 % and 2.00 % , and our base rate loans have applicable margins varying between zero and 1.00 % . Our average borrowing rate (including the impact of our interest rate derivatives; see Note 1 0 — Derivatives and Hedging Activity) was 2.3% and 2.2% for the three months ended September 30, 2015 and 2014, respectively, and 2.2% and 2.3% for the nine months ended September 30, 2015 and 2014, respectively . Our credit agreement contains certain financial covenants, including covenants that require that we maintain a consolidated leverage ratio of not greater than 3.25 :1 (except for the first quarter of each calendar year when the covenant requires us to maintain a consolidated leverage ratio of not greater than 3.5 :1 ) and a consolidated interest coverage ratio (the ratio of the sum of adjusted EBITDA (as defined in the credit agreement) and rental expense to the sum of cash interest expense and rental expense) of not less than 2.0 :1. At September 30, 2015 , under the definitions in the credit agreement, our consolidated leverage ratio was 1.3 and our consolidated interest coverage ratio was 4.9 . In addition, the credit agreement contains customary affirmative and negative covenants (subject to customary exceptions), including covenants that limit our ability to incur liens or other encumbrances, make investments, incur indebtedness, enter into mergers, consolidations and asset sales, change the nature of our business and engage in transactions with affiliates, as well as customary provisions with respect to events of default. We were in compliance with the covenants contained in our credit agreement at September 30, 2015 ; however, there can be no assurances that we will remain in compliance in the future.

Fair Value

Fair Value	9 Months Ended
	Sep. 30, 2015
Fair Value [Abstract]
Fair Value	1 2 . FAIR VALUE Fair value is defined as the price that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The inputs used to measure fair value are classified into the following hierarchy: Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities Level 2: Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability Level 3: Unobservable inputs for the asset or liability We endeavor to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. We utilize a third-party to value our interest rate derivatives. The interest rate derivatives are used to hedge the risk of variability from interest payments on our borrowings (see Note 10 – Derivatives and Hedging Activity). A majority of the inputs used in determining the fair value of the derivatives is derived mainly from Level 2 observations which include counterparty quotations in over the counter markets. However, the credit valuation adjustments associated with the derivatives utilize Level 3 inputs , such as estimates of current credit spreads , to evaluate the likelihood of default by ourselves and our counterparties. We determined that these adjustments are not significant to the overall valuation of our derivatives. As a result, our interest rate derivatives are classified in Level 2 in the fair value hierarchy. In certain instances our acquisitions provide for deferred contingent acquisition payments. These deferred payments are recorded at fair value at the time of acquisition and are included in other current and/or non-current liabilities on our consolidated balance sheets. We estimate the fair value of our deferred contingent acquisition liabilities using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value. The significant unobservable inputs used in the fair value measurements of our deferred contingent acquisition liabilities are our measures of the future profitability and related cash flows and discount rates. The fair value of the deferred contingent acquisition liabilities is reassessed on a quarterly basis based on assumptions provided to us by segment and business area leaders in conjunction with our corporate development and finance departments . Any change in the fair value estimate is recorded in the earnings of that period. During the nine months ended September 30, 2015 and 2014 , we recorded $ 1 2.6 million and $ 4 . 4 million , respectively, in other operating costs (benefit) for a net reduction in the liability reflecting changes in the fair value estimate of the contingent consideration for certain acquisitions made in 2014, 2013, and 2012 (see Note 2 – Acquisitions). Also during the nine months ended September 30, 2015 , the contingent consideration liability related to the Cymetrix acquisition was reclassified as a definitive consideration liability (see Note 2 – Acquisitions). The following table summarizes the changes in deferred contingent acquisition liabilities (in thousands): For the nine months ended September 30, 2015 2014 Beginning Balance $ $ Acquisitions Accretion of acquisition-related contingent consideration Remeasurement of acquisition-related contingent consideration Payments Reclassification to definitive consideration liability - Ending Balance $ $ At September 30, 2015 , the carrying value of our bank debt approximated fair value as it bears interest at variable rates . We consider the recorded value of our other financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable and accounts payable, to approximate the fair value of the respective assets and liabilities at September 30, 2015 based upon the short-term nature of the assets and liabilities. The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis at September 30, 2015 and December 31, 2014 ( in thousands): Quoted Prices in Active Markets for Significant Other Significant Identical Assets Observable Inputs Unobservable Inputs (Level 1) (Level 2) (Level 3) Total At September 30, 2015 Interest rate derivatives, net $ — $ $ — $ Deferred contingent acquisition liabilities $ — $ — $ $ At December 31, 2014 Interest rate derivatives, net $ — $ $ — $ Deferred contingent acquisition liabilities $ — $ — $ $

Other Operating Costs (Benefit)

Other Operating Costs (Benefit)	9 Months Ended
	Sep. 30, 2015
Other Operating Costs (Benefit) [Abstract]
Other Operating Costs (Benefits)	13. OTHER OPERATING COSTS (BENEFIT) Contingent Acquisition Liability Adjustment, Net During the three months ended September 30, 2014, we recorded a benefit of $ 0. 8 million, relating to fair value adjustments to our estimated deferred contingent acquisition liabilities (see Note 12 – Fair Value). During the nine months ended September 30, 2015 and 2014, we recorded a benefit of $12.6 million and $4.4 million, respectively, relating to fair value adjustments to our estimated deferred contingent acquisition liabilities (see Note 12 – Fair Value). The adjustment made in 2015 relates primarily to our Cymetrix acquisition. Contingent acquisition liabilities are initially estimated based on expected performance at the acquisition date and subsequently re viewed each quarter (see Note 12 – Fair Value). Office Consolidation, Net During the nine months ended September 30, 2015 , we recorded a cost of $2.7 million related to our new consolidated office space located in New York, New York which we took possession of on October 22, 2014. The cost includes future rent expense, net of expected sublease income, accelerated depreciation and deferred rent relating to the old space and rent expense for duplicate rent as we occupied our old New York offices un til completion of the build-out of the new space. We have recorded $ 3.5 million in current and non-current liabilities for restructured real estate. The activity for the nine months ended September 30, 2015 was as follows: Office Space Reductions Balance at December 31, 2014 $ Cost to operations during the nine months ended September 30, 2015 Deferred rent liability Utilized during the nine months ended September 30, 2015 Balance at September 30, 2015 $ Goodwill impairment During the nine months ended September 30, 2014 , we recorded a pretax goodwill impairment of $122.0 million. See Note 5 – Goodwill and Intangible Assets, Net.

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2015
Acquisitions [Abstract]
Schedule Of Supplemental Unaudited Pro Forma Financial Information	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Total revenues $ $ $ $ Net income (loss) from continuing operations $ $ $ $ Basic net income (loss) from continuing operations per basic share $ $ $ $ Shares used in computing net income (loss) per basic share Diluted net income (loss) from continuing operations per diluted share $ $ $ $ Shares used in computing net income (loss) per diluted share

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2015
Segment Information [Abstract]
Schedule Of Segment Revenues Before Reimbursements, Segment Total Revenues And Segment Operating Profit	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Revenues before reimbursements: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total revenues before reimbursements $ $ $ $ Total revenues: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total revenues $ $ $ $ Segment operating profit: Disputes, Investigations & Economics $ $ $ $ Financial, Risk & Compliance Healthcare Energy Total segment operating profit Segment reconciliation to income (loss) from continuing operations before income tax expense (benefit): Reconciling items: General and administrative expenses Depreciation expense Amortization expense Other operating costs (benefit), net Long-term compensation expense attributable to client-service employees (including share-based compensation expense) Operating income (loss) Interest and other expense, net Income (loss) from continuing operations before income tax expense (benefit) $ $ $ $
Total Assets By Segment	September 30, December 31, 2015 2014 Disputes, Investigations & Economics $ $ Financial, Risk & Compliance Healthcare Energy Unallocated assets Total assets $ $

Goodwill And Intangible Asset21

Goodwill And Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2015
Goodwill And Intangible Assets, Net [Abstract]
Schedule Of Goodwill Balance	September 30, December 31, 2015 2014 Goodwill $ $ Less - accumulated amortization Less - accumulated goodwill impairment Goodwill, net $ $
Schedule Of Change In Carrying Values Of Goodwill Assets By Segment	Disputes, Financial, Investigations Risk & Total & Economics Compliance Healthcare Energy Company Goodwill, net as of January 1, 2014 $ $ $ $ $ Acquisitions - - Impairment - - - Adjustments - Foreign currency - Goodwill, net as of September 30, 2014 $ $ $ $ $ Goodwill, net as of January 1, 2015 Acquisitions - - - Adjustments - Foreign currency Goodwill, net as of September 30, 2015 $ $ $ $ $
Schedule Of Finite-Lived Intangible Assets By Major Category	September 30, December 31, 2015 2014 Intangible assets: Customer lists and relationships $ $ Non-compete agreements Other Intangible assets, at cost Less: accumulated amortization Intangible assets, net $ $
Schedule Of Intangible Assets Estimated Useful Lives	Weighted Average Category Remaining Years Amount Customer lists and relationships, net 6.8 $ Non-compete agreements, net 3.5 Other intangible assets, net 2.7 Total intangible assets, net 6.2 $
Schedule Of Amortization Expense	Year Ending December 31, Amount 2015 ( October -December) $ 2016 2017 2018 2019 Thereafter Total $

Net Income Per Share (EPS) (Tab

Net Income Per Share (EPS) (Tables)	9 Months Ended
	Sep. 30, 2015
Net Income Per Share (EPS) [Abstract]
Schedule Of Weighted Average Number Of Shares	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Basic shares Employee stock options - Restricted stock and restricted stock units - Contingently issuable shares - Diluted shares Antidilutive shares (1) (1) Stock options with exercise prices greater than the average market price of our common stock during the respective time periods were excluded from the computation of diluted shares because the impact of including the shares subject to these stock options in the diluted share calculation would have been antidilutive. Due to a net loss applicable to common stockholders for the nine months ended September 30, 2014, we excluded 1,256 in potentially dilutive securities from the computation for the same period as their effect would be antidilutive.

Share-Based Compensation Expe23

Share-Based Compensation Expense (Tables)	9 Months Ended
	Sep. 30, 2015
Share-Based Compensation Expense [Abstract]
Schedule Of Share-Based Compensation Expense Showing Amount Attributable To Each Category	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Amortization of restricted stock and restricted stock unit awards $ $ $ $ Amortization of stock option awards Discount given on employee stock purchase transactions through our Employee Stock Purchase Plan Total share-based compensation expense $ $ $ $
Schedule Of Total Share-Based Compensation Expense	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Cost of services before reimbursable expenses $ $ $ $ General and administrative expenses Total share-based compensation expense $ $ $ $

Supplemental Consolidated Bal24

Supplemental Consolidated Balance Sheet Information (Tables)	9 Months Ended
	Sep. 30, 2015
Supplemental Consolidated Balance Sheet Information [Abstract]
Components Of Accounts Receivable	September 30, December 31, 2015 2014 Billed amounts $ $ Engagements in process Allowance for uncollectible billed amounts Allowance for uncollectible engagements in process Accounts receivable, net $ $
Components Of Prepaid Expenses And Other Current Assets	September 30, December 31, 2015 2014 Notes receivable - current $ $ Prepaid recruiting and retention incentives - current Other prepaid expenses and other current assets Prepaid expenses and other current assets $ $
Components Of Other Assets	September 30, December 31, 2015 2014 Notes receivable - non-current $ $ Capitalized client-facing software Prepaid recruiting and retention incentives - non-current Prepaid expenses and other non-current assets Other assets $ $
Property And Equipment	September 30, December 31, 2015 2014 Furniture, fixtures and equipment $ $ Software Leasehold improvements Property and equipment, at cost Less: accumulated depreciation and amortization Property and equipment, net $ $
Components Of Other Current Liabilities	September 30, December 31, 2015 2014 Deferred acquisition liabilities $ $ Deferred revenue Deferred rent - short term Other current liabilities Total other current liabilities $ $
Components Of Other Non-Current Liabilities	September 30, December 31, 2015 2014 Deferred acquisition liabilities $ $ Deferred rent - long term Other non-current liabilities Total other non-current liabilities $ $

Accumulated Other Comprehensi25

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2015
Accumulated Other Comprehensive Loss [Abstract]
Summary Of Activity In Accumulated Other Comprehensive Loss	For the three months ended For the nine months ended September 30, September 30, 2015 2014 2015 2014 Unrealized loss on foreign exchange: Balance at beginning of period $ $ $ $ Unrealized loss on foreign exchange Balance at end of period $ $ $ $ Unrealized gain (loss) on derivatives: Balance at beginning of period $ $ $ $ Unrealized gain (loss) on derivatives in period, net of reclassification Reclassified to interest expense Income tax expense Balance at end of period $ $ $ $ 2015 2014 Accumulated other comprehensive loss at September 30, $ $

Derivatives And Hedging Activ26

Derivatives And Hedging Activity (Tables)	9 Months Ended
	Sep. 30, 2015
Derivatives And Hedging Activity [Abstract]
Schedule Of Interest Rate Derivatives	Number of Total Notional Amount Month executed Contracts Beginning Date Maturity Date Rate (millions) December 2011 2 December 31, 2012 December 31, 2015 $10.0 May 2012 1 June 28, 2013 May 27, 2016 $5.0 July 2014 5 July 11, 2014 July 11, 2017 $30.0 March 2015 1 May 29, 2015 May 31, 2018 $10.0 June 2015 1 June 30, 2015 June 30, 2018 $5.0

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2015
Fair Value [Abstract]
Changes In The Deferred Contingent Consideration Liabilities	For the nine months ended September 30, 2015 2014 Beginning Balance $ $ Acquisitions Accretion of acquisition-related contingent consideration Remeasurement of acquisition-related contingent consideration Payments Reclassification to definitive consideration liability - Ending Balance $ $
Schedule Of Assets And Liabilities Measured At Fair Value On Recurring Basis	Quoted Prices in Active Markets for Significant Other Significant Identical Assets Observable Inputs Unobservable Inputs (Level 1) (Level 2) (Level 3) Total At September 30, 2015 Interest rate derivatives, net $ — $ $ — $ Deferred contingent acquisition liabilities $ — $ — $ $ At December 31, 2014 Interest rate derivatives, net $ — $ $ — $ Deferred contingent acquisition liabilities $ — $ — $ $

Other Operating Costs (Benefi28

Other Operating Costs (Benefit) (Tables)	9 Months Ended
	Sep. 30, 2015
Other Operating Costs (Benefit) [Abstract]
Schedule Of Activity For Restructured Real Estate	Office Space Reductions Balance at December 31, 2014 $ Cost to operations during the nine months ended September 30, 2015 Deferred rent liability Utilized during the nine months ended September 30, 2015 Balance at September 30, 2015 $

Acquisitions (Narrative) (Detai

Acquisitions (Narrative) (Details) $ in Thousands	Oct. 01, 2015USD ($)	Feb. 23, 2015USD ($)employee	May. 14, 2014USD ($)employee	Aug. 31, 2014USD ($)	Jun. 30, 2015USD ($)	Mar. 31, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Dec. 31, 2014USD ($)item	Dec. 31, 2013USD ($)
Business Acquisition [Line Items]
Payments of contingent acquisition liabilities								$ 592	$ 107
Reclassification to definitive consideration liability								10,000
Purchase price allocation of goodwill							$ 571,846	579,876	571,846	$ 568,091	$ 615,343
Contingent acquisition liability adjustments, net							(834)	(12,625)	(4,438)
Subsequent Event [Member]
Business Acquisition [Line Items]
Payments of contingent acquisition liabilities	$ 4,000
Healthcare [Member]
Business Acquisition [Line Items]
Purchase price allocation of goodwill							$ 205,216	$ 219,184	$ 205,216	$ 204,469	$ 129,191
RevenueMed, Inc [Member] | Healthcare [Member]
Business Acquisition [Line Items]
Date of acquisition								Feb. 23, 2015
Number of professionals in acquired entity | employee		1,500
Cash paid, at closing		$ 22,100
Contingent consideration, maximum target		$ 4,000
Contingent consideration, target period		6 months
Deferred contingent consideration liability, current		$ 3,800
Purchase price allocation of identifiable intangible assets		7,000
Purchase price allocation of goodwill		14,900
Purchase price allocation of internally developed software		1,400
Purchase price allocation of other net assets		2,600
Uncertain tax positions		$ 1,300
Cymetrix [Member] | Healthcare [Member]
Business Acquisition [Line Items]
Date of acquisition								May 14, 2014
Number of professionals in acquired entity | employee			600
Cash paid, at closing			$ 76,900
Contingent consideration, maximum target			$ 25,000
Contingent consideration, target period			1 year
Date agreement was amended								May 15, 2015
Reclassification to definitive consideration liability								$ 10,000
Deferred contingent consideration liability, non-current			$ 20,300
Purchase price allocation of goodwill			71,300
Cash			1,400
Accounts receivable, net			11,300
Other current assets			1,600
Property and equipment, net			11,800
Intangible assets			18,000
Total liabilities			$ 36,900
Contingent acquisition liability adjustments, net					$ 2,100	$ 15,400
Leerink, HLP and Assay [Member]
Business Acquisition [Line Items]
Cash paid, at closing				$ 9,300
Purchase price				$ 11,800
Number of businesses acquired | item										3

Acquisitions (Schedule Of Suppl

Acquisitions (Schedule Of Supplemental Unaudited Pro Forma Financial Information) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Acquisitions [Abstract]
Total revenues	$ 230,258	$ 233,479	$ 688,986	$ 670,865
Net income (loss) from continuing operations	$ 14,176	$ 16,149	$ 47,085	$ (49,733)
Basic net income (loss) from continuing operations per basic share	$ 0.30	$ 0.33	$ 0.98	$ (1.02)
Shares used in computing net income (loss) per basic share	47,835	48,736	48,036	48,856
Diluted net income (loss) from continuing operations per diluted share	$ 0.29	$ 0.32	$ 0.96	$ (1.02)
Shares used in computing net income (loss) per diluted share	49,155	49,827	49,297	48,856

Dispositions (Details)

Dispositions (Details) - Healthcare [Member] - Disposal Group, Not Discontinued Operations [Member] $ in Millions	Oct. 01, 2014USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Date of disposition	Oct. 1, 2014
Proceeds from disposition, net of selling costs	$ 1.5
Gain on disposition	0.5
Goodwill disposition	0.8
Intangible assets disposition	0.1
Other assets disposition	$ 0.2

Segment Information (Schedule O

Segment Information (Schedule Of Segment Revenues Before Reimbursements, Segment Total Revenues And Segment Operating Profit) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Segment Reporting Information [Line Items]
Total revenues before reimbursements	$ 209,634	$ 205,534	$ 621,813	$ 567,094
Total revenues	230,258	230,139	686,868	635,984
Total segment operating profit	70,617	72,002	205,295	192,942
General and administrative expenses	36,629	34,067	111,362	101,406
Depreciation expense	5,954	5,116	17,033	14,378
Amortization expense	2,084	1,673	6,650	4,668
Other operating costs (benefit), net	283	(834)	(9,504)	117,811
Long-term compensation expense attributable to client-service employees (including share-based compensation expense)	2,714	2,327	9,181	8,627
Operating income (loss)	22,953	29,653	70,573	(53,948)
Interest and other expense, net	613	1,829	3,330	4,172
Income (loss) from continuing operations before income tax (benefit) expense	22,340	27,824	67,243	(58,120)
Disputes, Investigations & Economics [Member]
Segment Reporting Information [Line Items]
Total revenues before reimbursements	80,099	79,862	237,808	232,188
Total revenues	86,826	85,518	255,552	250,046
Total segment operating profit	28,445	27,264	78,435	78,195
Financial, Risk & Compliance [Member]
Segment Reporting Information [Line Items]
Total revenues before reimbursements	28,302	37,251	92,754	100,855
Total revenues	31,069	44,878	107,808	121,100
Total segment operating profit	10,383	17,246	36,654	44,255
Healthcare [Member]
Segment Reporting Information [Line Items]
Total revenues before reimbursements	74,500	62,964	212,739	162,145
Total revenues	80,821	69,035	230,802	179,877
Total segment operating profit	24,091	18,726	67,073	48,230
Energy [Member]
Segment Reporting Information [Line Items]
Total revenues before reimbursements	26,733	25,457	78,512	71,906
Total revenues	31,542	30,708	92,706	84,961
Total segment operating profit	$ 7,698	$ 8,766	$ 23,133	$ 22,262

Segment Information (Total Asse

Segment Information (Total Assets By Segment) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	$ 977,022	$ 903,493
Disputes, Investigations & Economics [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	344,095	322,014
Financial, Risk & Compliance [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	86,808	83,834
Healthcare [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	310,692	289,229
Energy [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	110,137	103,218
Unallocated Assets [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	$ 125,290	$ 105,198

Goodwill And Intangible Asset34

Goodwill And Intangible Assets, Net (Goodwill Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	May. 31, 2015	May. 31, 2014
Goodwill [Line Items]
Goodwill impairment				$ 122,045
Amortization expense	$ 2,084	$ 1,673	$ 6,650	4,668
Healthcare [Member]
Goodwill [Line Items]
Percentage of fair value of reporting unit in excess of carrying value					25.00%
Energy [Member]
Goodwill [Line Items]
Percentage of fair value of reporting unit in excess of carrying value					32.00%
Financial, Risk & Compliance [Member]
Goodwill [Line Items]
Percentage of fair value of reporting unit in excess of carrying value					61.00%
Disputes, Investigations & Economics [Member]
Goodwill [Line Items]
Percentage of fair value of reporting unit in excess of carrying value					16.00%
Percentage of carrying amount in excess of fair value						1.00%
Goodwill impairment				$ 122,045

Goodwill And Intangible Asset35

Goodwill And Intangible Assets, Net (Finite-Lived Intangible Assets Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 2,084	$ 1,673	$ 6,650	$ 4,668
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated remaining useful lives			10 years

Goodwill And Intangible Asset36

Goodwill And Intangible Assets, Net (Schedule Of Goodwill Balance) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
Goodwill And Intangible Assets, Net [Abstract]
Goodwill	$ 707,346	$ 695,561
Less - accumulated amortization	(5,425)	(5,425)
Less - accumulated goodwill impairment	(122,045)	(122,045)
Goodwill, net	$ 579,876	$ 568,091	$ 571,846	$ 615,343

Goodwill And Intangible Asset37

Goodwill And Intangible Assets, Net (Schedule Of Change In Carrying Values Of Goodwill Assets By Segment) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Goodwill [Line Items]
Balance as of the beginning of the period - Goodwill, net	$ 568,091	$ 615,343
Acquisitions	14,854	79,134
Impairment		(122,045)
Adjustments	(151)	(151)
Foreign currency	(2,918)	(435)
Balance as of the end of the period - Goodwill, net	579,876	571,846
Disputes, Investigations & Economics [Member]
Goodwill [Line Items]
Balance as of the beginning of the period - Goodwill, net	231,730	354,221
Acquisitions		3,100
Impairment		(122,045)
Adjustments	(116)	(116)
Foreign currency	(2,837)	(442)
Balance as of the end of the period - Goodwill, net	228,777	234,718
Financial, Risk & Compliance [Member]
Goodwill [Line Items]
Balance as of the beginning of the period - Goodwill, net	55,320	55,330
Adjustments	(26)	(26)
Foreign currency	45	12
Balance as of the end of the period - Goodwill, net	55,339	55,316
Healthcare [Member]
Goodwill [Line Items]
Balance as of the beginning of the period - Goodwill, net	204,469	129,191
Acquisitions	14,854	76,034
Adjustments	(9)	(9)
Foreign currency	(130)
Balance as of the end of the period - Goodwill, net	219,184	205,216
Energy [Member]
Goodwill [Line Items]
Balance as of the beginning of the period - Goodwill, net	76,572	76,601
Foreign currency	4	(5)
Balance as of the end of the period - Goodwill, net	$ 76,576	$ 76,596

Goodwill And Intangible Asset38

Goodwill And Intangible Assets, Net (Schedule Of Finite-Lived Intangible Assets By Major Category) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Goodwill And Intangible Assets, Net [Abstract]
Customer lists and relationships	$ 100,451	$ 95,616
Non-compete agreements	22,647	22,326
Other	25,640	26,520
Intangible assets, at cost	148,738	144,462
Less: accumulated amortization	(121,908)	(117,960)
Intangible assets, net	$ 26,830	$ 26,502

Goodwill And Intangible Asset39

Goodwill And Intangible Assets, Net (Schedule Of Intangible Assets Estimated Useful Lives) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Intangible assets remaining amortization, Weighted Average Remaining Years	6 years 2 months 12 days
Intangible assets remaining amortization, Amount	$ 26,830	$ 26,502
Customer Lists and Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets remaining amortization, Weighted Average Remaining Years	6 years 9 months 18 days
Intangible assets remaining amortization, Amount	$ 22,720
Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets remaining amortization, Weighted Average Remaining Years	3 years 6 months
Intangible assets remaining amortization, Amount	$ 1,781
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets remaining amortization, Weighted Average Remaining Years	2 years 8 months 12 days
Intangible assets remaining amortization, Amount	$ 2,329

Goodwill And Intangible Asset40

Goodwill And Intangible Assets, Net (Schedule Of Amortization Expense) (Details) $ in Thousands	Sep. 30, 2015USD ($)
Goodwill And Intangible Assets, Net [Abstract]
2015 (October-December)	$ 1,968
2,016	7,307
2,017	5,361
2,018	3,873
2,019	2,624
Thereafter	5,697
Total	$ 26,830

Net Income Per Share (EPS) (Det

Net Income Per Share (EPS) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Basic shares	47,835,000	48,736,000	48,036,000	48,856,000
Contingently issuable shares	63,000	35,000	75,000
Diluted shares	49,155,000	49,827,000	49,297,000	48,856,000
Antidilutive shares	271,000	93,000	252,000	1,362,000
Potentially dilutive securities excluded from the computation as their effect would be anti-dilutive				1,256
Employee Stock Options [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Share-based awards	103,000	186,000	106,000
Restricted Stock And Restricted Stock Units [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Share-based awards	1,154,000	870,000	1,080,000

Share-Based Compensation Expe42

Share-Based Compensation Expense (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2015USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation costs related to the outstanding or unvested stock-based compensation awards	$ 16.2
Weighted average remaining vesting period	2 years
Restricted Stock Units And Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate share-based awards granted | shares	1,158,311
Aggregate fair value of share-based awards granted	$ 14.8

Share-Based Compensation Expe43

Share-Based Compensation Expense (Schedule Of Total Share-Based Compensation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-Based Compensation Expense [Abstract]
Amortization of restricted stock and restricted stock unit awards	$ 2,424	$ 1,681	$ 7,413	$ 6,363
Amortization of stock option awards	197	186	570	572
Discount given on employee stock purchase transactions through our Employee Stock Purchase Plan	61	63	223	231
Total share-based compensation	$ 2,682	$ 1,930	$ 8,206	$ 7,166

Share-Based Compensation Expe44

Share-Based Compensation Expense (Schedule Of Share-Based Compensation Expense Showing Amount Attributable To Different Categories) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-Based Compensation Expense [Abstract]
Cost of services before reimbursable expenses	$ 1,512	$ 1,215	$ 4,879	$ 3,840
General and administrative expenses	1,170	715	3,327	3,326
Total share-based compensation	$ 2,682	$ 1,930	$ 8,206	$ 7,166

Supplemental Consolidated Bal45

Supplemental Consolidated Balance Sheet Information (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Feb. 23, 2015
Supplemental Consolidated Balance Sheet Information [Line Items]
Capitalized client-facing software, additions			$ 600	$ 2,400
Transfer of property, plant, and equipment			500
Unsecured employee loans issued			$ 4,900	0
Employee retention and signing bonuses, term, years			6 years
Sign-on and retention bonuses issued			$ 18,500	11,200
Investment in property, plant and equipment			31,160	15,065
Proceeds from tenant allowance	$ 1,100
Disposals of fully depreciated assets			19,900
Contingent acquisition liability adjustments, net		$ (834)	(12,625)	$ (4,438)
Performance-based long-term incentive compensation liabilities	$ 1,100		1,100
Technology Infrastructure and Software [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Investment in property, plant and equipment			13,800
Technology Infrastructure and Software Previously Accrued [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Investment in property, plant and equipment			2,300
Leasehold Improvements [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Investment in property, plant and equipment			14,000
Furniture [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Investment in property, plant and equipment			$ 3,400
Maximum [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Lease expiration year			2,025
Healthcare [Member] | RevenueMed, Inc [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Property and equipment acquired			$ 2,300
Deferred contingent consideration liability, current					$ 3,800
Restricted Stock Units (RSUs) [Member]
Supplemental Consolidated Balance Sheet Information [Line Items]
Vesting period			3 years

Supplemental Consolidated Bal46

Supplemental Consolidated Balance Sheet Information (Components Of Accounts Receivable) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Supplemental Consolidated Balance Sheet Information [Abstract]
Billed amounts	$ 145,933	$ 135,787
Engagements in process	95,564	69,704
Allowance for uncollectible billed amounts	(9,405)	(10,847)
Allowance for uncollectible engagements in process	(10,933)	(6,992)
Accounts receivable, net	$ 221,159	$ 187,652

Supplemental Consolidated Bal47

Supplemental Consolidated Balance Sheet Information (Components Of Prepaid Expenses And Other Current Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Supplemental Consolidated Balance Sheet Information [Abstract]
Notes receivable - current	$ 3,503	$ 3,701
Prepaid recruiting and retention incentives - current	9,879	8,633
Other prepaid expenses and other current assets	17,154	14,808
Prepaid expenses and other current assets	$ 30,536	$ 27,142

Supplemental Consolidated Bal48

Supplemental Consolidated Balance Sheet Information (Components Of Other Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Supplemental Consolidated Balance Sheet Information [Abstract]
Notes receivable - non-current	$ 5,061	$ 3,401
Capitalized client-facing software	1,633	2,163
Prepaid recruiting and retention incentives - non-current	14,062	7,482
Prepaid expenses and other non-current assets	2,990	4,340
Other assets	$ 23,746	$ 17,386

Supplemental Consolidated Bal49

Supplemental Consolidated Balance Sheet Information (Property And Equipment) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 176,719	$ 164,294
Less: accumulated depreciation and amortization	(101,144)	(103,677)
Property and equipment, net	75,575	60,617
Furniture, Fixtures and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	62,363	65,077
Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	74,622	65,410
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 39,734	$ 33,807

Supplemental Consolidated Bal50

Supplemental Consolidated Balance Sheet Information (Components Of Other Current Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Supplemental Consolidated Balance Sheet Information [Abstract]
Deferred acquisition liabilities	$ 17,207	$ 26,202
Deferred revenue	14,505	16,405
Deferred rent - short term	2,727	3,006
Other current liabilities	3,202	6,913
Total other current liabilities	$ 37,641	$ 52,526

Supplemental Consolidated Bal51

Supplemental Consolidated Balance Sheet Information (Components Of Other Non-Current Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Supplemental Consolidated Balance Sheet Information [Abstract]
Deferred acquisition liabilities	$ 211	$ 1,760
Deferred rent - long-term	14,823	9,015
Other non-current liabilities	5,611	3,612
Total other non-current liabilities	$ 20,645	$ 14,387

Accumulated Other Comprehensi52

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning of period			$ (12,084)
Balance at end of period	$ (15,265)	$ (9,479)	(15,265)	$ (9,479)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning of period	(12,217)	(8,437)	(11,973)	(9,129)
Unrealized gain (loss)	(2,723)	(950)	(2,967)	(258)
Balance at end of period	(14,940)	(9,387)	(14,940)	(9,387)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning of period	(220)	(169)	(111)	(212)
Unrealized gain (loss)	(186)	5	(450)	(29)
Reclassified to interest expense	135	121	394	249
Income tax expense	(54)	(49)	(158)	(100)
Balance at end of period	$ (325)	$ (92)	$ (325)	$ (92)

Derivatives And Hedging Activ53

Derivatives And Hedging Activity (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Derivative [Line Items]
Ineffectiveness related to the interest rate derivatives			$ 0
Interest expense	$ 1,018,000	$ 1,942,000	3,988,000	$ 4,177,000
Interest Rate Derivatives [Member]
Derivative [Line Items]
Interest expense			400,000	$ 200,000
Liability related to interest rate derivatives	$ 500,000		$ 500,000

Derivatives And Hedging Activ54

Derivatives And Hedging Activity (Schedule Of Interest Rate Derivatives) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2015USD ($)contract
Interest Rate Contract December 2011 [Member]
Derivative [Line Items]
Number of contracts | contract	2
Beginning date	Dec. 31, 2012
Maturity date	Dec. 31, 2015
Rate	1.17%
Total notional amount	$ 10
Interest Rate Contract May 2012 [Member]
Derivative [Line Items]
Number of contracts | contract	1
Beginning date	Jun. 28, 2013
Maturity date	May 27, 2016
Rate	1.15%
Total notional amount	$ 5
Interest Rate Contract July 2014 [Member]
Derivative [Line Items]
Number of contracts | contract	5
Beginning date	Jul. 11, 2014
Maturity date	Jul. 11, 2017
Rate	1.10%
Total notional amount	$ 30
Interest Rate Contract March 2015 [Member]
Derivative [Line Items]
Number of contracts | contract	1
Beginning date	May 29, 2015
Maturity date	May 31, 2018
Rate	1.47%
Total notional amount	$ 10
Interest Rate Contract June 2015 [Member]
Derivative [Line Items]
Number of contracts | contract	1
Beginning date	Jun. 30, 2015
Maturity date	Jun. 30, 2018
Rate	1.40%
Total notional amount	$ 5

Bank Debt (Narrative) (Details)

Bank Debt (Narrative) (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015USD ($)	Sep. 30, 2014	Sep. 30, 2015USD ($)	Sep. 30, 2014	Dec. 31, 2014USD ($)
Line of Credit Facility [Line Items]
Revolving credit facility	$ 400		$ 400
Maximum borrowing capacity	500		$ 500
Maturity date of bank borrowings			Sep. 1, 2018
Aggregate bank borrowings	146.8		$ 146.8		$ 109.8
Additional bank borrowings	$ 232		$ 232
Credit agreement, average borrowing rate	2.30%	2.20%	2.20%	2.30%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Additional bank borrowings	$ 7.6		$ 7.6
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Consolidated leverage ratio			1.3
Consolidated interest coverage ratio			4.9
Revolving Credit Facility [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Consolidated interest coverage ratio			2
Revolving Credit Facility [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Consolidated leverage ratio			3.25
Maximum consolidated leverage ratio first quarter of every calendar year			3.5
LIBOR [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	1.00%		1.00%
LIBOR [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	1.00%		1.00%
LIBOR [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	2.00%		2.00%
Base Rate [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	0.00%		0.00%
Base Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	0.00%		0.00%
Base Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt facility, applicable margin	1.00%		1.00%

Fair Value (Narrative) (Details

Fair Value (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Fair Value [Abstract]
Contingent acquisition liability adjustments, net	$ (834)	$ (12,625)	$ (4,438)

Fair Value (Changes In The Defe

Fair Value (Changes In The Deferred Contingent Consideration Liabilities) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Fair Value [Abstract]
Beginning Balance		$ 23,272	$ 6,322
Acquisitions		3,765	20,285
Accretion of acquisition-related contingent consideration		1,075	1,383
Remeasurement of acquisition-related contingent consideration	$ (834)	(12,625)	(4,438)
Payments of contingent acquisition liabilities		(592)	(107)
Reclassification to definitive consideration liability		(10,000)
Ending Balance	$ 23,445	$ 4,895	$ 23,445

Fair Value (Schedule Of Assets

Fair Value (Schedule Of Assets And Liabilities Measured At Fair Value On Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate derivatives, net	$ 544	$ 184
Deferred contingent acquisition liabilities	4,895	23,272	$ 23,445	$ 6,322
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate derivatives, net	544	184
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred contingent acquisition liabilities	$ 4,895	$ 23,272

Other Operating Costs (Benefi59

Other Operating Costs (Benefit) (Narrative) (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Other Income and Other Expense [Line Items]
Contingent acquisition liability adjustments, net	$ (834)	$ (12,625)	$ (4,438)
Rent expense during office consolidation		(2,740)
Goodwill impairment			$ 122,045
Office Space Reductions [Member]
Other Income and Other Expense [Line Items]
Restructured real estate		$ 3,458		$ 242

Other Operating Costs (Benefi60

Other Operating Costs (Benefit) (Schedule Of Activity For Restructured Real Estate) (Details) - Office Space Reductions [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)
Restructuring Cost and Reserve [Line Items]
Balance at December 31, 2014	$ 242
Cost to operations during the nine months ended September 30, 2015	1,354
Deferred rent liability	2,661
Utilized during the nine months ended September 30, 2015	(799)
Balance at September 30, 2015	$ 3,458